The Pot Report. Get the Report
The week in cannabis, in five minutes.Free, every week, from The Pot Report.
Get the Report

Medical

Medical · Kentucky · November 16, 2026

More than 30k Kentuckians are registered cardholders in state’s medical marijuana program

Kentucky's medical marijuana program now has more than 30,000 registered cardholders, according to Lt. Gov. Jacquelin Coleman. She said over 500 practitioners can issue certifications, and the opening of Speakeasy Dispensary in Maysville brings the state to 27 operating dispensaries across all 11 licensing regions, with 47 of 80 approved businesses open.

Why it matters: A cardholder base above 30,000 and a dispensary network that now covers every licensing region suggest access is widening for Kentucky patients. More certifying practitioners should make it easier to get a card, and with more than half of approved businesses open, patients can expect more places to buy as others launch.

Read moreSource: nkytribune.com

Medical · November 16, 2026

Cannabis use disorder linked to higher odds of suicidal thoughts – Medical Xpress

Adults with cannabis use disorder have 57% higher odds of suicidal thoughts than adults without it, according to a Journal of Studies on Alcohol and Drugs study. Researchers analyzed more than 415,000 U.S. adults from a national drug survey and found the gap held steady from 2014 through 2023, across age, sex and racial and ethnic groups.

Why it matters: The findings point to a mental health risk tied to problematic use, not to cannabis use in general, and the authors say the study does not prove cause. The steady figure over a decade of wider legal access is reassuring. Still, the researchers want clinicians to ask people seeking help for cannabis use disorder directly about suicidal thoughts.

Read moreSource: medicalxpress.com

Medical · November 16, 2026

Is Alcohol or Marijuana Worse for Your Brain? – VICE

Psychiatrist Daniel Amen says alcohol kills more people than marijuana, yet in his clinics' brain imaging study of 62,454 SPECT scans, both substances sped up brain aging and marijuana did worse. Amen Clinics ranks cannabis use disorder second only to schizophrenia for accelerating brain aging and advises cutting back on both substances.

Why it matters: The marijuana vs alcohol brain debate rarely has a clean winner. Amen's clinic data suggests cannabis use disorder in particular is tied to faster brain aging, while alcohol carries its own heavy risks. For consumers and patients, the claims point to heavy or disordered use as the sticking point, though the findings come from one clinic's research.

Read moreSource: vice.com

Medical · Oklahoma · November 16, 2026

Federally Funded Study to Investigate Workplace Health Risks in Oklahoma Cannabis Industry

A University of Oklahoma researcher has won a federal grant to study workplace health risks in Oklahoma's medical cannabis industry. The CDC's National Institute for Occupational Safety and Health funded the work, which builds on a pilot study of worker exposures such as elevated carbon dioxide from plants and particulate matter from trimming and manufacturing. Hongwan (Melodi) Li leads the project.

Why it matters: Cannabis workers rarely get dedicated federal attention on job safety. Data on air quality and dust exposure in grow rooms and processing areas could eventually shape workplace standards, and that affects the people who produce the medicine patients buy. For consumers, it is a sign that regulators are starting to look at how products are made, not just sold.

Read moreSource: Ganjapreneur

Medical · November 16, 2026

Boots to begin prescribing medical cannabis in UK – The Guardian

Boots has launched SureLeaf, an online medical cannabis prescribing service, making it the first UK high street pharmacy to do so. Patients aged 25 and over with eligible conditions such as chronic pain, anxiety or insomnia can apply. A clinical team reviews each case, and a research programme with the University of Nottingham will track outcomes.

Why it matters: A household-name pharmacy entering the medical cannabis market signals that prescribing is moving further into the mainstream. Patients get another route to a prescription, with a second consultant review and regular check-ins promised. Yet recent research found very little evidence for several conditions clinics treat, so access is widening faster than proof.

Read moreSource: theguardian.com

Medical · Maine, Vermont · November 15, 2026

On the trail of pot, and help for my daughter with Rett syndrome

In a personal column, journalist Neil Genzlinger describes giving his daughter Abby, who has Rett syndrome, a CBD and CBG extract bought legally by mail from a Vermont seller. The family is testing whether CBD for Rett syndrome eases her anxiety, and he links it to a 1979 Maine marijuana story he covered as a young reporter.

Why it matters: The column shows how legal cannabis extracts have become something families try for hard-to-treat symptoms, bought by mail without a prescription. It is one parent's experiment, not evidence, and he says it is ongoing. It also reflects an old argument that research into cannabis benefits deserved more attention than prosecution.

Read moreSource: rettsyndromenews.com

The week in cannabis, in five minutes.Free, every week, from The Pot Report.
Get the Report
Medical · November 15, 2026

Report: Australia Medical Cannabis Market to Reach $2.6B by 2035

The Australia medical cannabis market is forecast to pass $2.67 billion by 2035, according to a Market.us Media report. It put the market at about $781.6 million in 2025 and projects annual growth of 13.1% over the next decade. The report says hemp-based products hold a 54.1% share, and the Therapeutic Goods Administration regulates the program.

Why it matters: A forecast is not a guarantee, but it points to a program that keeps widening. For patients in Australia, the drivers the report names, including better product availability and more acceptance among healthcare professionals, suggest easier access over time. For US readers, it shows medical cannabis demand growing under a national regulator.

Read moreSource: Ganjapreneur

Medical · November 15, 2026

Millions of Americans use marijuana to sleep, but new study raises troubling questions

A Northwestern Medicine study of 1,266 people tracked for nearly 35 years found cannabis and sleep may not mix well. Wrist monitors showed lifetime and recent users slept objectively worse than non-users, with more disruption and lower efficiency, though users did not rate their own sleep as poorer. The study did not look at how people consumed cannabis.

Why it matters: Many people turn to cannabis to sleep, and this research challenges that habit. Users judged their own sleep as fine while wrist monitors showed otherwise, so how rested someone feels may not match what is happening overnight. The findings show an association, not proof of cause, and researchers say long-term effects need further study.

Read moreSource: foxnews.com

Medical · November 15, 2026

Study links cannabis use to poorer objectively measured sleep | Межа

A study of 1,266 people found that cannabis and sleep quality are linked in a worrying way: heavier use was tied to worse sleep on wrist-monitor measures, even though participants did not say they slept badly. Researchers followed cannabis use for nearly 35 years, then tracked sleep for a week in middle age. Findings are due at an American Heart Association meeting.

Why it matters: Many people use cannabis hoping it will help them sleep. These results suggest that how rested someone feels may not match what a monitor records. Study author Mercedes Carnethon says the data do not back cannabis as a sleep aid. The study did not look at how people consumed it, so questions remain about smoking versus edibles.

Read moreSource: mezha.net

Medical · Kentucky · November 13, 2026

Surveyed cancer patients say cannabis improves symptoms – Medical Xpress

A University of Kentucky study of 237 radiation patients found that cannabis for cancer symptoms is common, with most recent users reporting relief. Just over half had used unprescribed cannabis at some point, and about 15% had used it since diagnosis. Of 35 recent users, 80% said their main symptom improved.

Why it matters: Patients are already using cannabis for pain, nausea and anxiety during cancer care, and nearly all recent users in the survey said they would raise it with their doctors. The researchers caution that self-reported data cannot show cannabis caused the relief. The findings point to a gap: patients want conversations that many rural oncologists feel untrained to have.

Read moreSource: medicalxpress.com